Creating Hope Reauthorization Act

Bill: 116-s-4010
Sponsor: full_name: Sen. Casey, Robert P., Jr. [D-PA]
Introduced: 2020-06-18
Policy area: Health
Subjects: Child health

Drug safety, medical device, and laboratory regulation

Health programs administration and funding

Health promotion and preventive care

Infectious and parasitic diseases
Latest action: action_date: 2020-06-18
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2020-06-18
action_desc: Introduced in Senate
text: <p><b>Creating Hope Reauthorization Act</b></p> <p>This bill permanently reauthorizes a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)</p>

tv_txt: II 116th CONGRESS 2d Session S. 4010 IN THE SENATE OF THE UNITED STATES June 18, 2020 Mr. Casey (for himself and Ms. Collins ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To amend the Federal Food, Drug, and Cosmetic Act to make permanent the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.

1. Short title This Act may be cited as the Creating Hope Reauthorization Act . 2. Providing for permanent authority to issue priority review vouchers to encourage treatments for rare pediatric diseases Section 529(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360ff(b) ) is amended by striking paragraph (5).